The Food and Drug Administration has been meeting with OpenAI to discuss the agency’s use of AI, according to sources with knowledge of the meetings. The meetings appear to be part of a broader effort ...
(Reuters) -OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology news platform Wired reported on Wednesday, citing sources with ...
Hosted on MSN
FDA, OpenAI discussing use of AI for drug evaluation
The US Food and Drug Administration (FDA) has been meeting with OpenAI to explore how AI could help make the drug approval process faster and more efficient. This effort is part of a broader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results